The Progressive Corporation is an American insurance company. It is one of the largest providers of car insurance in America. The company insures motorcycles, boats, RVs and commercial vehicles, and provides home insurance through select companies. Progressive has expanded internationally as well, offering car insurance in Australia. The company was co-founded in 1937 by Jack Green and Joseph M. Lewis, and is headquartered in Mayfield Village, Ohio. Progressive ranked No. 112 in the 2018 Fortune 500 list of the largest United States corporations by total revenue. view company details
Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing novel therapies for central nervous system (CNS) disorders in the United States. Its product pipeline includes AXS-05, which is in the Phase III clinical trial for the treatment resistant depression; Phase II/III clinical trials in agitation associated with Alzheimer's disease; and Phase II clinical trial for the treatment of smoking cessation, as well as for major depressive disorder. The company is also developing AXS-07, which is in Phase III clinical trial for the treatment of migraine; AXS-12 that... view company details
Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with locally advanced or metastatic breast cancer. The company was founded in 2013 and is based in San Diego, California. view company details
Diversified manufacturer. Products include outdoor electronic equipment enclosures for the telecommunications industry. NEMA rated enclosures. OSP enclosures. Wireless (3G & 4G) enclosures. Electronic enclosures. Custom metal enclosures. Backhaul enclosures. Cross Connect cabinets. PON cabinets Subsidiaries include: Bridge Machine Company, LLC www.bridgeonline.com A-One Manufacturing www.a-onemfg.com Dustshield, LLC www.dustshield.com Press Room Equipment www.pressroomequipment.com Norwalk Innovations www.norwalkinnovations.com view company details
Fox Home Innovations, LLC is a premier design/build remodeling & construction company operating in the Manhattan, KS area. Our team is dedicated to providing our clients with the best customer service and quality of work possible. view company details
LA Fitness International LLC (doing business as LA Fitness) is an American gym chain with more than 700 clubs across the United States and Canada. The company was formed in 1984 and is based in Irvine, California. view company details
Medley Management Inc. is an investment holding company and operate and control all of the business and affairs of Medley LLC and its subsidiaries. Medley Management Inc. was incorporated on June 13, 2014 and is based in New York, New York. view company details
Ardelyx, Inc., a specialized biopharmaceutical company, develops and sells medicines for the treatment of cardio renal diseases in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial for the treatment of hyperphosphatemia in end-stage renal disease patients on dialysis. It also develops RDX013, a small molecule potassium secretagogue program for the treatment of patients with hyperkalemia. The co... view company details
CytoDyn Inc., a clinical-stage biotechnology company, focuses on the clinical development and commercialization of humanized monoclonal antibodies for the treatment and prevention of human immunodeficiency virus (HIV) infection. Its lead product is PRO 140, a therapeutic anti-viral agent, which is in Phase IIb treatment substitution trial, Phase IIb extension study, Phase IIb/III pivotal trial, and Phase IIb/III investigative trial for HIV; and Phase II trial for graft-versus-host disease. The company has strategic agreement with Samsung BioLogics Co. Ltd. for the clinical and commercial manuf... view company details
Eiger BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare diseases in the United States and internationally. The company's lead program is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trial for treating hepatitis delta virus (HDV) infection. Its product candidates also include Lambda, which targets type III IFN receptors; Lonafarnib for the treatment of progeria and progeroid laminopathies; Avexitide for treating post-bariatric hypoglycemia; and Ubenimex, an o... view company details
Savara Inc. operates as an orphan lung disease company. Its lead product candidate includes Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis; and in Phase IIa development stage for treating nontuberculous mycobacterial lung infection. The company is also developing AeroVanc, an inhaled vancomycin that is in Phase III stage for the treatment of methicillin-resistant Staphylococcus aureus lung infection in individuals living with cystic fibrosis. Savara Inc. is headquarte... view company details
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing RNA interference (RNAi) therapeutics. The company's pipeline of investigational RNAi therapeutics focus on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system/ocular diseases. It provides ONPATTRO (patisiran), a lipid complex injection for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. The company's development programs include Vutrisiran, an investigational RNAi therapeutic targeti... view company details
The City of Coachella is a municipal corporation that provides full service governmental services to the residents and businesses of the City of Coachella. It is a city in the County of Riverside, California; it is the easternmost city in the region collectively known as the Coachella Valley. It is located 28 miles (45 km) east of Palm Springs, 72 miles (116 km) east of Riverside, and 130 miles (210 km) east of Los Angeles. Known as the "City of Eternal Sunshine", Coachella is largely a rural and agricultural community in the desert and one of the state's fastest growing cities in the late 20t... view company details
At CB2 we're known for our unique take on design. The magic is in the mix of edgy and elevated. Raw and refined. We love trends but don't live by them. We're more into that timeless cool-factor. Home is where personal style comes to life. And we're here to inspire in any way we can. To help you fill your home with things you love, that aren't too expensive and that you'll never regret. As a brand, we champion inclusivity, kindness, love and respect. We try to be good corporate citizens and take big and small actions towards that goal everyday. CB2 enthusiastically supports Humble Design Chicag... view company details
We understand drug development in the clinical trial setting. Since our founding in 2008, we have successfully completed 213 medical studies and clinical trials for the treatment of medical and central nervous system conditions, with an additional 21 currently enrolling as of January 2016. We deliver reliable, verifiable, cutting edge research and clinical trial results by thoroughly planning for every study, carefully and compassionately evaluating subjects, and adhering precisely to protocol throughout our clinical trials process. We provide superior performance combined with quality data - ... view company details
Tribune Publishing Company, a media company, publishes newspapers worldwide. The company operates in two segments, M and X. It publishes daily newspapers; weekly newspapers; and digital platforms, such as Websites and mobile applications. The company also provides various digital marketing services, which include the development of mobile Websites, search engine marketing and optimization, social media account management, and content marketing for its customers' Web presence for small to medium size businesses. In addition, it offers TCA, a syndication and licensing business that provides dail... view company details
Intrexon Corporation engage in the engineering and industrialization of biology in the United States. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that consist of key genetic components. It provides reproductive technologies and other genetic processes to cattle breeders and producers; biological insect control solutions; technologies for non-browning apple without the use of artificial additives; genetically engineered swine for medical and genetic research; commercial aquaculture products; an... view company details
Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of drugs directed against nuclear transport and related targets for the treatment of cancer and other diseases. Its lead drug candidate is Selinexor(KPT-330), which is in Phase IIb clinical study in treatments of refractory multiple myeloma; Phase Ib/II clinical study in combination with backbone treatments for multiple myeloma patients; Phase III clinical trial in combination with Velcade (bortezomib) and dexamethasone for multiple myeloma patients; Phase IIb cli... view company details
Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, which is in Phase III clinical trials to treat moderate to moderately severe post-operative pain. The company was founded in 2015 and is based in New York, New York. view company details
Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. Its lead product candidate includes KORSUVA (CR845/ difelikefalin) injection, which is in Phase III clinical trial for the treatment of patients with chronic kidney disease (CKD) associated pruritus undergoing hemodialysis, as well as in Phase II/... view company details